PISKEL KYLE bought ADPT
November 28, 2025 · Form 4 insider transaction
PISKEL KYLE bought 94,384 shares of Adaptive Biotechnologies Corporation at $12.14 per share, a transaction worth $1.15M. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
94,384
Price
$12.14
Total value
$1.15M
InsiderPISKEL KYLE
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 28, 2025
Filing dateDecember 2, 2025
Shares owned after379,457
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 28, 2025.